A Sampling of Clips for 
September 15, 2005

* UCSD faculty and staff may obtain a copy of an article by e-mailing the University Communications Office

F.D.A. Advisory Panel Backs an Anemia Drug
New York Times, Sept. 15-A federal advisory panel recommended approval yesterday of Celgene's drug Revlimid, a chemical cousin of thalidomide, as a treatment for a potentially fatal blood disorder. (Quote by Dr. Joanne E. Mortimer of the UCSD Rebecca and John Moores Cancer Center.) More

Kids and Fatty Liver Disease
Channel 8, Austin, Sept. 14-According to a recent report by the Institute of Medicine, about 9 million American kids older than age 6 are considered obese. (Quote by Dr. Joel Lavine, a professor of pediatrics at UCSD.) More

Drivers Use Less Gasoline for Second Week
Houston Chronicle, Sept. 15-The second consecutive week of reports showing a drop in U.S. drivers' demand for gasoline has observers wondering if high energy prices are finally starting to crack the economy's sturdy facade. (Quote by James Hamilton, a professor of economics at UCSD.) More